Sir John Burn | |
---|---|
![]() Linda and John Burn at the Moth Club in Hackney, London, on 8 November 2021 | |
Born | [1] | 6 February 1952
Education | Barnard Castle Grammar School |
Alma mater | Newcastle University (MB BS, MD) |
Known for | Centre for Life [2] Human Variome Project [3] |
Spouse | Linda Marjorie Wilson (m. 1972) |
Awards | Knight Bachelor (2010) [1] |
Scientific career | |
Fields | Cancer Genetics [4] |
Institutions | Newcastle University Great Ormond Street Hospital [5] Royal Victoria Infirmary [1] |
Thesis | Cardiovascular malformation : an analysis of genetic contribution (1991) |
Website | www |
Sir John Burn (born 6 February 1952) [1] is a British professor of Clinical Genetics at Newcastle University and senior leader in England's National Health Service. [5] [6] [4] [2]
Burn was born and raised in the North East of England. He was educated at Barnard Castle Grammar School, (now Teesdale School) [1] and Newcastle University Medical School from 1976 to 1980 where he was awarded a Bachelor of Medical Sciences (BMedSci) degree in 1973, a Bachelor of Medicine, Bachelor of Surgery (MB BS) in 1976 and a Doctor of Medicine (MD) degree in 1991. [1] [7]
Burn has been Professor of Clinical Genetics at Newcastle University since 1991 and a consultant specialist since 1984. [8] He is a recognised authority on the genetics of cancer. [2] [9] [10] [11] He led the regional NHS Genetics Service for 20 years and helped to create the Centre for Life which houses an education and science centre alongside the Institute of Genetic Medicine [8] and Northgene Ltd, [12] the identity testing company he launched in 1995. He chairs DNA device company QuantuMDx. [13]
Between 2014 and 2018, he was a non-executive director of NHS England. [14] [15] In 2016, he was appointed Executive Chairman of Global Variome Ltd, a not-for-profit company supporting services to the international coordination work of the Human Variome Project. [16] [3] [17]
In 2017, he became Chair of Newcastle upon Tyne Hospitals NHS Foundation Trust. [18] His term as chair of the trust ended in 2024, and was taken over by Professor Kath McCourt. [19]
In 2010, Burn was appointed Knight Bachelor by Her Majesty Queen Elizabeth II for outstanding services to medicine. [20]
He was chosen as one of the first 20 ‘local heroes’ to be commemorated with a brass plaque on Newcastle Quayside in 2014, and the following year, he received the Living North award for services to the North East 2000 – 2015. [21] [22]
The Harveian Oration 2019 was delivered by Burn, his lecture ‘Prediction and prevention in the genomic era’, outlined the history of genetic medicine, presented the challenges in using genetics to predict medical conditions and explained how he looks forward to seeing if we can use its full potential to prevent disease in the future. [23]
In 2020, Burn was selected as the incumbent of the 2020 Niehaus, Southworth, Weissenbach Award and Visiting Professorship in Clinical Cancer Genetics at Memorial Sloan Kettering Cancer Center. The award recognises leaders in the translation of germline genetics to preventive care of cancer patients and their families. Due to COVID-19 restrictions, Burn did not receive his award and present his lecture until May 2021.
He was interviewed by Jim Al-Khalili for The Life Scientific on Radio 4 first broadcast in February 2018. [2]
Burn's daughter, son in law and grandkids earned national fame since the first lockdown in 2020 with a series of entertaining and quirky cover versions performed in their front room. The family surprised Burn with their Prostatectomy song, in homage to the successful operation he had to remove his prostate. [24]
Genetic counseling is the process of investigating individuals and families affected by or at risk of genetic disorders to help them understand and adapt to the medical, psychological and familial implications of genetic contributions to disease. This field is considered necessary for the implementation of genomic medicine. The process integrates:
The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.
Li–Fraumeni syndrome (LFS) is a rare, autosomal dominant, hereditary disorder that predisposes carriers to cancer development. It was named after two American physicians, Frederick Pei Li and Joseph F. Fraumeni Jr., who first recognized the syndrome after reviewing the medical records and death certificates of childhood rhabdomyosarcoma patients. The disease is also known as SBLA, for the Sarcoma, Breast, Leukemia, and Adrenal Gland cancers that it is known to cause.
Hereditary nonpolyposis colorectal cancer (HNPCC) is a hereditary predisposition to colon cancer.
Succinate dehydrogenase complex subunit C, also known as succinate dehydrogenase cytochrome b560 subunit, mitochondrial, is a protein that in humans is encoded by the SDHC gene. This gene encodes one of four nuclear-encoded subunits that comprise succinate dehydrogenase, also known as mitochondrial complex II, a key enzyme complex of the tricarboxylic acid cycle and aerobic respiratory chains of mitochondria. The encoded protein is one of two integral membrane proteins that anchor other subunits of the complex, which form the catalytic core, to the inner mitochondrial membrane. There are several related pseudogenes for this gene on different chromosomes. Mutations in this gene have been associated with pheochromocytomas and paragangliomas. Alternatively spliced transcript variants have been described.
Sir Walter Fred Bodmer is a German-born British human geneticist.
Reproductive medicine is a branch of medicine concerning the male and female reproductive systems. It encompasses a variety of reproductive conditions, their prevention and assessment, as well as their subsequent treatment and prognosis.
Homeobox protein engrailed-2 is a protein that in humans is encoded by the EN2 gene. It is a member of the engrailed gene family.
Homeobox protein Hox-B13 is a protein that in humans is encoded by the HOXB13 gene.
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.
Genomics England is a company set up and owned by the United Kingdom Department of Health and Social Care to run the 100,000 Genomes Project. The project aimed in 2014 to sequence 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. An infectious disease strand is being led by Public Health England.
The 100,000 Genomes Project is a now-completed UK Government project managed by Genomics England that is sequencing whole genomes from National Health Service patients. The project is focusing on rare diseases, some common types of cancer, and infectious diseases. Participants give consent for their genome data to be linked to information about their medical condition and health records. The medical and genomic data is shared with researchers to improve knowledge of the causes, treatment, and care of diseases. The project has received over £300 million from public and private investment.
Richard Cotton AM was an Australian medical researcher and founder of the Murdoch Institute and the Human Variome Project. Cotton focused on the prevention and treatment of genetic disorders and birth defects.
Sir Douglass Matthew Turnbull is professor of neurology at Newcastle University, an honorary consultant neurologist at Newcastle upon Tyne Hospitals NHS Foundation Trust and a director of the Wellcome Trust Centre for Mitochondrial Research.
Charis Eng was a Singaporean American physician-scientist and geneticist at the Cleveland Clinic, notable for identifying the PTEN gene. She was the chairwoman and founding director of the Genomic Medicine Institute of the Cleveland Clinic, founding director and attending clinical cancer geneticist of the institute's clinical component, the Center for Personalized Genetic Healthcare, and professor and vice chairwoman of the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine.
Rosalind Anne Eeles is a Professor of Oncogenetics at the Institute of Cancer Research and clinician at the Royal Marsden NHS Foundation Trust. She is a leader in the field of genetic susceptibility to prostate cancer, and is known for the discovery of 14 genetic variants involved in prostate cancer predisposition. According to ResearchGate, Eeles has published more than 500 articles in peer-reviewed journals, with over 34,000 citations and an h-index of 92. Eeles was elected a Fellow of the Academy of Medical Science in 2012. She was awarded a National Institute for Health Research Senior Investigator Emeritus in 2014.
Benjamin James Challacombe is a British consultant urological surgeon at Guy's & St Thomas' Hospitals, and at King’s College London, who specialises in the treatment of kidney and prostatic disease using robotic surgery. In 2005, he was part of the team that published the results of a randomised controlled trial of human versus telerobotics in the field of urology and renal transplant, one of the first of its kind.
Christine Patch is a nurse and genetic counsellor. She is a Principal Staff Scientist in Genomic Counselling in the Society and Ethics Research group, part of Wellcome Connecting Science, based on the Wellcome Genome Campus. She is also the Clinical Lead for Genetic Counselling at Genomics England, and a former President of the European Society of Human Genetics.
Patrick Francis Chinnery is a neurologist, clinician scientist, and Wellcome Trust Principal Research Fellow based in the Medical Research Council Mitochondrial Biology Unit and the University of Cambridge, where he is also professor of neurology and head of the department of clinical neurosciences.
Alexander (Sasha) Gusev is a computational biologist and an associate professor of medicine at Harvard Medical School and the Dana Farber Cancer Institute.